A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle
about
Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosisAssociation of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYSMZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile dataPlasma Acylcarnitines and Amino Acid Levels As an Early Complex Biomarker of Propensity to High-Fat Diet-Induced Obesity in MiceApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureMulti-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analysesMass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition researchAcquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study.Fatty fish intake decreases lipids related to inflammation and insulin signaling--a lipidomics approach.Differences in muscle and adipose tissue gene expression and cardio-metabolic risk factors in the members of physical activity discordant twin pairs.Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunityLipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.Human tear fluid lipidome: from composition to function.Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.Metabolic regulation in progression to autoimmune diabetesSystematic analysis of choline-containing phospholipids using multi-dimensional mass spectrometry-based shotgun lipidomicsInformatics and computational strategies for the study of lipids.Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.Lipidome and transcriptome profiling of pneumolysin intoxication identifies networks involved in statin-conferred protection of airway epithelial cells.An Efficient Single Phase Method for the Extraction of Plasma Lipids.Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat DietIndividualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutionsTranslational biomarkers of acetaminophen-induced acute liver injuryAccurate quantification of lipid species by electrospray ionization mass spectrometry - Meet a key challenge in lipidomics.Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model.A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intakeHigh-throughput electronic biology: mining information for drug discovery.Gender-dependent progression of systemic metabolic states in early childhood.Comparative phospholipid profiles of control and glaucomatous human trabecular meshworkGlobal metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.Lipidomics of familial longevityDysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetesHepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.Towards a molecular characterisation of pathological pathways.Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why?Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.
P2860
Q21202801-88B53903-6E3B-4221-BBA1-35220E0BE087Q24320093-EAE4D41B-1BB5-4D1F-8A64-2DCD123DDB0CQ27136473-75892B94-A9CC-41D0-A955-C9553703BB5DQ27346382-0A52485B-A145-4406-A493-749ED5E0CBFEQ28074451-6CF4DA88-F0C9-4640-8BB6-D1283720EECCQ28732813-612EA4BD-E0A6-44B8-B1B2-EA77D3AA60DEQ29014502-F792DE83-6847-438A-A3E7-8A94462294EEQ30829796-84F55F78-3566-42F5-8EDE-06DF25DE7156Q33350242-AEC05309-FFFD-486F-B928-DC76F74CB0D6Q33434417-415E8D0C-043D-4584-8EAC-4E915D2E814CQ33700641-95EEF3C7-3132-4131-A569-9E730F804406Q33756790-0CD8B33C-399A-4836-8F40-A0B71915DB0BQ33824051-DE174F88-C106-4224-A815-D82305BBCB50Q33900724-F9C10FB7-B4DE-493E-BEB5-1C701C8D03E2Q33947257-E9276856-C26B-46C4-A104-72DCD27D992DQ33978080-14E6AE6C-3049-4223-8684-A2029F3417CCQ34064185-534374D4-A04F-40B9-844D-BCDFED048919Q34121957-EC49A4A2-4E35-4215-9227-22BEE44A3520Q34739639-F6FBE8EE-6E3D-4B49-BC8E-E78E67C9C3FDQ35063271-4980F32C-4651-4FDC-8592-35724B512E80Q35174188-075A15E7-0CBF-4892-AAE2-134D8E698834Q35577707-8D2380DD-5B41-4372-9D07-81640175188DQ35663656-545A8CA2-E84E-4665-A73B-A7B067E91E52Q35829914-B65A713F-6DA0-47D2-A077-56C227A49944Q35848129-01807975-66DA-4BDA-99D9-187CC3BAEC5DQ35915932-F2E6AC9E-0CBE-49CC-953B-B57FF4AD48F8Q36001451-A8796EC5-D8A0-44CC-A4A5-48CF0E0D89F7Q36168194-4147B15E-B73A-4425-A182-0A5008051918Q36179961-A95538C0-7623-43C1-879E-C3F828529F29Q36301541-0D629D3C-1185-47C1-8F82-6153195E4F07Q36748142-F1FA1FD7-F864-4F4F-8105-12CC358C79BCQ36790273-7B06C9DB-2552-4F58-A133-A3F33887A8D1Q36807917-88BA6D20-7BAB-4B00-8B2C-F442FCA4D58DQ36816026-BF9E4CB5-F803-46D2-A0E7-7D22C962FDDEQ37005030-0584E76B-E027-4175-9F3D-E1D6590C3FAEQ37019642-291C1854-2DAB-4EC8-B209-3A94CB2D17BEQ37023053-13A0C179-7CAA-495E-B7C2-DE0294DAD9B3Q37087531-147BC17F-0F02-4711-96F1-62D3FF69B53EQ37099149-5E004204-B707-4A79-BA6F-400F868F1686Q37149236-27EFFCBF-909B-452B-AD7C-4EABBD4125F6
P2860
A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A systems biology strategy rev ...... atin-induced changes in muscle
@ast
A systems biology strategy rev ...... atin-induced changes in muscle
@en
A systems biology strategy rev ...... atin-induced changes in muscle
@nl
type
label
A systems biology strategy rev ...... atin-induced changes in muscle
@ast
A systems biology strategy rev ...... atin-induced changes in muscle
@en
A systems biology strategy rev ...... atin-induced changes in muscle
@nl
prefLabel
A systems biology strategy rev ...... atin-induced changes in muscle
@ast
A systems biology strategy rev ...... atin-induced changes in muscle
@en
A systems biology strategy rev ...... atin-induced changes in muscle
@nl
P2093
P2860
P50
P3181
P1433
P1476
A systems biology strategy rev ...... atin-induced changes in muscle
@en
P2093
Dieter Lütjohann
Hannu Päivä
Lilli Saarinen
Marko Sysi-Aho
Mikko Katajamaa
Päivi Junni
Reijo Laaksonen
Rudy Van Coster
P2860
P3181
P356
10.1371/JOURNAL.PONE.0000097
P407
P577
2006-12-20T00:00:00Z